# Fatty Acid Supplementation in Children With ASD (Study 2)

> **NCT04312932** · PHASE2 · COMPLETED · sponsor: **Sarah Keim** · enrollment: 98 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** LCPUFA Oil Supplement
- **DIETARY_SUPPLEMENT:** Canola Oil Placebo

## Key facts

- **NCT ID:** NCT04312932
- **Lead sponsor:** Sarah Keim
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2023-11-28
- **Final completion:** 2024-04-11
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2025-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04312932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04312932, "Fatty Acid Supplementation in Children With ASD (Study 2)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04312932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*